Table 1 Baseline characteristics of all episodes of uncomplicated malaria treated with study drugs
Characteristic | Treatment Group | |
|---|---|---|
| Â | AL (n = 412) | DP (n = 425) |
Treatment episodes per child, median (range) | 2 (1-11) | 2 (1-9) |
Age at time of treatment in months, mean (SD) | 12.5 (3.6) | 12.6 (3.8) |
   4-10 months, n (%) | 104 (25%) | 118 (28%) |
   >10-12 months, n (%) | 111 (27%) | 114 (27%) |
   >12-15 months, n (%) | 85 (21%) | 78 (18%) |
   >15-22 months, n (%) | 112 (27%) | 115 (27%) |
HIV status, TS use, ARV use | Â | Â |
   HIV-uninfected not taking TS, n (%) | 248 (60%) | 271 (64%) |
   HIV-uninfected taking TS, n (%) | 115 (28%) | 121 (28%) |
   HIV-infected only taking TS, n (%) | 8 (1.9%) | 8 (1.9%) |
   HIV-infected taking TS and ARVs, n (%) | 41 (10%) | 25 (5.9%) |
Duration since last study drug treatment | Â | Â |
   17 - 28 days, n (%) | 76 (18%) | 18 (4.2%) |
   28 - 63 days, n (%) | 146 (35%) | 192 (45%) |
   >63 days or no prior treatment, n (%) | 190 (46%) | 215 (51%) |